Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuminori Sakurai

Showing results (51-60 of 170) with videos related to

Pageof 17
Sort By:
Molecular Therapy. Nucleic Acids|March 23, 2017
Type I Interferons Impede Short Hairpin RNA-Mediated RNAi via Inhibition of Dicer-Mediated Processing to Small Interfering RNAMitsuhiro Machitani, Fuminori Sakurai, Keisaku Wakabayashi, et al.
Human Gene Therapy|March 21, 2006
Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicityNaoya Koizumi, Kenji Kawabata, Fuminori Sakurai, et al.
Case Reports in Urology|March 24, 2018
A Case of Early Stage Bladder Carcinosarcoma in Late Recurrence of Urothelial Carcinoma after Transurethral ResectionDaisaku Hirano, Toshiyuki Yoshida, Daigo Funakoshi, et al.
Biological & Pharmaceutical Bulletin|December 4, 2018
LY341495, an mGluR2/3 Antagonist, Regulates the Immunosuppressive Function of Myeloid-Derived Suppressor Cells and Inhibits Melanoma Tumor GrowthNaosuke Morikawa, Masashi Tachibana, Yukio Ago, et al.
Biochemical and Biophysical Research Communications|March 12, 2016
Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cellsRyosuke Negoro, Kazuo Takayama, Yasuhito Nagamoto, et al.
Journal of Virology|December 4, 2003
Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablationNaoya Koizumi, Hiroyuki Mizuguchi, Fuminori Sakurai, et al.
Anticancer Research|January 25, 2023
Treatment of Human Pancreatic Cancers Following Local and Systemic Administration of Oncolytic Adenovirus Serotype 35Ryosuke Ono, Kosuke Takayama, Rika Onishi, et al.
Journal for Immunotherapy of Cancer|July 10, 2025
Oncolytic adenovirus serotype 35 mediated tumor growth suppression <i>via</i> efficient activation of antitumor immunityRyosuke Ono, Sora Tokuoka, Masashi Tachibana, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 10, 2005
Efficient regulation of gene expression using self-contained fiber-modified adenovirus vectors containing the tet-off systemHiroyuki Mizuguchi, Zhi-Li Xu, Fuminori Sakurai, et al.
Biological & Pharmaceutical Bulletin|July 3, 2018
Generation of the Adenovirus Vector-Mediated CRISPR/Cpf1 System and the Application for Primary Human Hepatocytes Prepared from Humanized Mice with Chimeric LiverTomohito Tsukamoto, Eiko Sakai, Shunsuke Iizuka, et al.
Pageof 17

Showing results (51-60 of 170) with videos related to

Sort By:
Pageof 17
Molecular Therapy. Nucleic Acids|March 23, 2017
Type I Interferons Impede Short Hairpin RNA-Mediated RNAi via Inhibition of Dicer-Mediated Processing to Small Interfering RNAMitsuhiro Machitani, Fuminori Sakurai, Keisaku Wakabayashi, et al.
Human Gene Therapy|March 21, 2006
Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicityNaoya Koizumi, Kenji Kawabata, Fuminori Sakurai, et al.
Case Reports in Urology|March 24, 2018
A Case of Early Stage Bladder Carcinosarcoma in Late Recurrence of Urothelial Carcinoma after Transurethral ResectionDaisaku Hirano, Toshiyuki Yoshida, Daigo Funakoshi, et al.
Biological & Pharmaceutical Bulletin|December 4, 2018
LY341495, an mGluR2/3 Antagonist, Regulates the Immunosuppressive Function of Myeloid-Derived Suppressor Cells and Inhibits Melanoma Tumor GrowthNaosuke Morikawa, Masashi Tachibana, Yukio Ago, et al.
Biochemical and Biophysical Research Communications|March 12, 2016
Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cellsRyosuke Negoro, Kazuo Takayama, Yasuhito Nagamoto, et al.
Journal of Virology|December 4, 2003
Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablationNaoya Koizumi, Hiroyuki Mizuguchi, Fuminori Sakurai, et al.
Anticancer Research|January 25, 2023
Treatment of Human Pancreatic Cancers Following Local and Systemic Administration of Oncolytic Adenovirus Serotype 35Ryosuke Ono, Kosuke Takayama, Rika Onishi, et al.
Journal for Immunotherapy of Cancer|July 10, 2025
Oncolytic adenovirus serotype 35 mediated tumor growth suppression <i>via</i> efficient activation of antitumor immunityRyosuke Ono, Sora Tokuoka, Masashi Tachibana, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 10, 2005
Efficient regulation of gene expression using self-contained fiber-modified adenovirus vectors containing the tet-off systemHiroyuki Mizuguchi, Zhi-Li Xu, Fuminori Sakurai, et al.
Biological & Pharmaceutical Bulletin|July 3, 2018
Generation of the Adenovirus Vector-Mediated CRISPR/Cpf1 System and the Application for Primary Human Hepatocytes Prepared from Humanized Mice with Chimeric LiverTomohito Tsukamoto, Eiko Sakai, Shunsuke Iizuka, et al.
Pageof 17